In vitro and in vivo studies show that muscle-derived IL-6 enhances lipolysis and fat oxidation through a mechanism involving AMPK activation [35] and that IL-6 autoantibodies appear to be involved in the pathogenesis of type 2 diabetes [36]. Here, IL6 is linked to type 2 diabetes mellitus.